The New York Times, May 20, 2020
Scientists are developing more than 100coronavirus vaccines using a range of techniques, some of which are well-established and some of which have never been approved for medical use before.
Most of these vaccines target the so-called spike proteins that cover the virus and help it invade human cells. The immune system can develop antibodies that latch onto spike proteins and stop the virus.
A successful vaccine for the SARS-CoV-2 coronavirus would teach people’s immune systems to make antibodies against the virus without causing disease.
Continue reading “Different Approaches to a Coronavirus Vaccine”